RecruitingNot Applicable

Prospective Study on Clinical Outcomes of Spontaneous Pneumothorax

Hong Kong349 participantsStarted 2022-10-01

Plain-language summary

Pneumothorax can be fatal if treatment is delayed or the pneumothorax is refractory. However, the mortality rates and their risk factors were mainly reported from retrospective studies, and local data regarding the mortality of spontaneous pneumothorax is scarce. This study aims at evaluating the in-hospital mortality and relevant clinical outcomes of spontaneous pneumothorax and identifying their predictive factors. The data collected from this study will also guide the planning of subsequent research to overcome the knowledge and service gap in managing spontaneous pneumothorax.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria * All patients with a confirmed diagnosis of spontaneous pneumothorax on admission or during the hospital stay * Age greater than 18 years old * Chinese ethnicity * Able to sign written informed consent to participate in the study Exclusion criteria * Pneumothorax was not found by thoracic imaging * Traumatic pneumothorax (including iatrogenic pneumothorax) * Pneumothorax with recent (within one month) lung resection surgery, that may be due to staple line issues * Trapped lung or non-expandable lungs, without evidence of air leakage * Patients with psychiatric disease or cognitive impairment that may limit their ability of understanding or giving consent to the study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

To evaluate the in-hospital mortality of spontaneous pneumothorax who admitted to the hospital

Timeframe: 36 months

Trial details

NCT IDNCT05397717

SponsorChinese University of Hong Kong

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-09-30

Contact for this trial

Ka Pang Chan, MBChB

35052211 chankapang@gmail.com

View on ClinicalTrials.gov More Pneumothorax, Spontaneous trials